Journal
SEMINARS IN THROMBOSIS AND HEMOSTASIS
Volume 36, Issue 8, Pages 917-924Publisher
THIEME MEDICAL PUBL INC
DOI: 10.1055/s-0030-1267045
Keywords
Acute promyelocytic leukemia; bleeding; thrombosis; microparticles; tissue factor; annexin A2
Categories
Ask authors/readers for more resources
Serious bleeding and thrombotic complications are frequent in acute promyelocytic leukemia (APL) and are major causes of morbidity and mortality. Microparticles (MP) have been used to study the risk and pathogenesis of thrombosis in many malignant disorders. To date, from published articles, this approach had not been applied to APL. In this article, the hemostatic dysfunction in this disorder is briefly reviewed. A study design to address this problem using MP is described. MP bearing tissue factor, profibrinolytic factors (tissue plasminogen activator and annexin A2), and the antifibrinolytic factor plasminogen activator inhibitor type 1 were measured using flow cytometry. The cellular origin of the MP was identified by specific cell surface markers. Comparison of the various populations of MP was made between samples collected at the time of diagnosis with those collected at molecular remission. Preliminary data suggest that this approach is feasible.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available